Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.
about
Reactive oxygen species: players in the cardiovascular effects of testosteroneSerum testosterone levels and mortality in men with CKD stages 3-4Low testosterone is associated with disability in men with multiple sclerosis.Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men.Hypogonadism and renal failure: An update.Body composition and survival in dialysis patients: results from an international cohort study.Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)?Testosterone is protective in the sexually dimorphic development of arthritis and lung disease in SKG mice.Male Sexual Dysfunction and Chronic Kidney DiseaseNonthyroidal illness and the cardiorenal syndrome.Role of testosterone in the pathogenesis, progression, prognosis and comorbidity of men with chronic kidney disease.Testosterone and mortality.Perspectives in Pediatric Pathology, Chapter 22. Testicular Involvement in Systemic Diseases.Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease.Update on Testosterone Replacement Therapy in Hypogonadal Men.Clinical relevance of sarcopenia in chronic kidney disease.Renal Osteodystrophy or Kidney-Induced Osteoporosis?Association between Testosterone and Mortality Risk among U.S. Males Receiving Dialysis.Resistance training and testosterone levels in male patients with chronic kidney disease undergoing dialysis.Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis.Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.Association of serum total testosterone concentration with skeletal muscle mass in men under hemodialysis.Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need.Testosterone and hemoglobin in hemodialysis male and female patients.Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.Anabolic deficiencies in men with systolic heart failure: do co-morbidities and therapies really contribute significantly?Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men.C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care.Frailty and chronic kidney disease: current evidence and continuing uncertainties.Bioavailable Testosterone Is Positively Associated With Bone Mineral Density in Male Kidney Transplantation Candidates.Systematic Literature Review of the Epidemiology of Nongenetic Forms of Hypogonadism in Adult Males
P2860
Q28602465-38EDECE6-94A1-42EE-AFE7-1E7B710FA88BQ34084357-058B5D16-742C-4456-87A6-E7346A649371Q34302567-D416D25A-ACB0-44E3-AC40-CDAE5D071D60Q35289581-175E530F-BCBB-4703-8F16-18DC7847888DQ35423143-F15C781D-BB04-4244-86D5-9F6F3A0D7C84Q35611214-B7D3E901-0C53-43D0-825B-96C57040059BQ35758553-70ACF852-116A-4DE7-BC41-C1916C707469Q36272964-6F3F444A-5055-4A50-B029-20197DBDBCD6Q36902118-64B6270D-3286-46E2-BF9D-A01B7C825271Q37714464-8F794478-A03C-496C-8952-D263A57785ADQ38133714-E3A299CD-223D-4563-B15B-AF97B6D9BD5FQ38151985-80CB9480-5624-4E85-98DE-9E37892882E0Q38231599-D4122B1B-EFC0-4BF4-8FC5-500C93BCC171Q38261745-F18EA9B2-4E8F-452F-BE78-BD45DEF7775FQ38359416-08E13327-E411-4241-A3AB-7C9DCE496C8CQ38528376-4EE67B0D-8134-4C66-9E8A-E593C2DAD7ECQ38757331-92F79149-70E6-4FD2-A659-1342367BB984Q39301592-A9291BE6-1E78-44DC-85EB-CE78157C4ED7Q40063034-6CE92726-6FDB-4A2A-A7F9-F3222C90F46DQ41271317-20055920-8735-43CD-9052-C8DF72E35DA8Q43419904-449CEF3F-10C0-4458-B706-73993519E14BQ43580426-1C282471-73FA-4FCB-AFEA-735A99ED0E1BQ47693568-A6100B3F-5175-40C8-9FE4-820C00A66D46Q48224940-206ABB1A-FE04-4AB3-AEE5-E62C593D8290Q48859501-E9CE4E98-1A03-4772-8327-0346E2D38AB4Q50535094-5139D59A-7D77-4564-9CD5-7810D7D11E2DQ50876472-B101F85D-E56B-4C44-A0E1-F3A69C9FCBD1Q50886876-BA219524-69BA-40E2-A62C-2A0D22657F11Q51723059-8E66986A-CD3B-4949-9E8D-369BA85BF531Q55035811-8FE1D9F0-3B44-486C-8F86-5E4E1FB36976Q55342099-2877339A-CDEF-47B3-B312-BEF07BF29B5FQ59048823-2743F65A-C89A-4C65-986F-C99F65D278EA
P2860
Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Prevalence and clinical implic ...... with end-stage renal disease.
@en
Prevalence and clinical implic ...... with end-stage renal disease.
@nl
type
label
Prevalence and clinical implic ...... with end-stage renal disease.
@en
Prevalence and clinical implic ...... with end-stage renal disease.
@nl
prefLabel
Prevalence and clinical implic ...... with end-stage renal disease.
@en
Prevalence and clinical implic ...... with end-stage renal disease.
@nl
P2860
P50
P356
P1476
Prevalence and clinical implic ...... n with end-stage renal disease
@en
P2093
Olof Heimbürger
Paolo Parini
P2860
P304
P356
10.1093/NDT/GFQ397
P407
P50
P577
2010-07-11T00:00:00Z